ERBB2 and breast cancer: Our data showed that both HER3 and IGF-1R directly interacted with HER2 in the trastuzumab-resistant BC sublines SKBR3-pool2 and BT474-HR20, which were derived from the parental BC cell lines SKBR3 and BT474, respectively [27].